Bard Phasix ST

Overview

Designed for a strong repair enables functional tissue remodeling

Phasix™ ST Mesh combines two market-leading technologies into one product: monofilament resorbable Phasix™ Mesh and a proven hydrogel barrier based on Sepra® technology. While the monofilament mesh supports functional healing and a strong repair, the hydrogel barrier minimizes tissue attachment to the visceral side of the mesh for intraabdominal placement.¹

These meshes are available in different shapes, such as round, rectangle, and square.

For high-risk/comorbid patients, surgeons have had to choose between permanent synthetic meshes and biologic grafts—and their inherent pros and cons. Synthetic meshes can have complications that lead to mesh removal or reoperation, while biologic grafts can have accelerated degradation in the presence of bacteria which may lead to mesh failure.

Phasix™ ST Mesh handles, sutures, and fixates like a synthetic mesh while exhibiting the remodeling characteristics of a biologic mesh. It facilitates trocar deployment during laparoscopic placement.